Dendritic cell immunoreceptor 2 (DCIR2) deficiency decreases hepatic conventional dendritic cell content but not the progression of diet‐induced obesity
Abstract Aims Inflammatory pathways and immune system dysregulation participate in the onset and progression of cardiometabolic diseases. The dendritic cell immunoreceptor 2 (DCIR2) is a C‐type lectin receptor mainly expressed by conventional type 2 dendritic cells, involved in antigen recognition a...
Main Authors: | Rossella Bellini, Annalisa Moregola, Jasmine Nour, Patrizia Uboldi, Fabrizia Bonacina, Giuseppe D. Norata |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-10-01
|
Series: | Immunity, Inflammation and Disease |
Subjects: | |
Online Access: | https://doi.org/10.1002/iid3.1024 |
Similar Items
-
Dendritic cell marker Clec4a4 deficiency limits atherosclerosis progression
by: Rossella Bellini, et al.
Published: (2023-03-01) -
Intradermal Delivery of Dendritic Cell-Targeting Chimeric mAbs Genetically Fused to Type 2 Dengue Virus Nonstructural Protein 1
by: Lennon Ramos Pereira, et al.
Published: (2020-10-01) -
Oct4 and Hypoxia Dual-Regulated Oncolytic Adenovirus Armed with shRNA-Targeting Dendritic Cell Immunoreceptor Exerts Potent Antitumor Activity against Bladder Cancer
by: Che-Yuan Hu, et al.
Published: (2023-09-01) -
Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies
by: Christian H. K. Lehmann, et al.
Published: (2016-03-01) -
The C-type lectin DCIR contributes to the immune response and pathogenesis of colorectal cancer
by: Giulia Trimaglio, et al.
Published: (2024-03-01)